Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Metastases”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Ended earlyNCT01545141
What this trial is testing

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
Roswell Park Cancer Institute 15
Not applicableUnknownNCT06091683
What this trial is testing

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)

Who this might be right for
Peritoneal Metastases From Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 10
Not applicableStudy completedNCT00481962
What this trial is testing

Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)

Who this might be right for
Peritonitis
Wyeth is now a wholly owned subsidiary of Pfizer 180
Testing effectiveness (Phase 2)UnknownNCT05204173
What this trial is testing

Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis

Who this might be right for
Gastric Cancer Stage IVPeritoneal Metastases
Ruijin Hospital 30
Not applicableStudy completedNCT01768936
What this trial is testing

Procalcitonin Ratio's Impact on the Decision Upon On-demand Relaparotomy in Septic Peritonitis

Who this might be right for
Secondary Peritonitis After Intestinal Perforation
CHIR-Net 234
Testing effectiveness (Phase 2)UnknownNCT04155671
What this trial is testing

POF Versus FOLFOX Plus IP Paclitaxel in AGC

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 260
Testing effectiveness (Phase 2)Ended earlyNCT05431907
What this trial is testing

Phase 1/2 Study Evaluating Safety and Potential Efficacy of Allocetra-OTS Via Pressurized Intra-Peritoneal Aerosol Chemotherapy as Add-on to Standard of Care Chemotherapy for Treatment of Peritoneal Metastasis

Who this might be right for
Peritoneal Metastases
Enlivex Therapeutics RDO Ltd. 9
Very early researchUnknownNCT06224738
What this trial is testing

Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases

Who this might be right for
Gastric Cancer
First People's Hospital of Hangzhou 9
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableLooking for participantsNCT07667192
What this trial is testing

Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer

Who this might be right for
Recurrent Gynecologic CancerRecurrent Uterine CancerRecurrent Cervical Cancer+5 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 500
Large-scale testing (Phase 3)Looking for participantsNCT07213804
What this trial is testing

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms+1 more
Eli Lilly and Company 1,630
Not applicableUnknownNCT05050253
What this trial is testing

Lavage With Super-Oxidized Solution for Secondary Peritonitis

Who this might be right for
Peritonitis
Insel Gruppe AG, University Hospital Bern 200
Not applicableLooking for participantsNCT06601075
What this trial is testing

The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)

Who this might be right for
Advanced Colorectal Cancer
Ruijin Hospital 30
Not applicableStudy completedNCT04744688
What this trial is testing

Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment

Who this might be right for
Peritoneal MetastasesPeritoneal CarcinomatosisColorectal Neoplasms Malignant+11 more
University of Aarhus 90
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Early research (Phase 1)UnknownNCT04913662
What this trial is testing

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis

Who this might be right for
Stomach NeoplasmPeritoneal Metastases
Seoul National University Bundang Hospital 18
Testing effectiveness (Phase 2)Study completedNCT03834272
What this trial is testing

Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies

Who this might be right for
Peritoneal Metastases
Lumicell, Inc. 18
Not applicableUnknownNCT04122885
What this trial is testing

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

Who this might be right for
Peritoneal CancerChemotherapy-Induced Change
University Hospital Tuebingen 60
Not applicableNot Yet RecruitingNCT05661110
What this trial is testing

Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 46
Next Page